Transfer of Subjects From Subutex/Suboxone to RBP-6300

NCT01582347 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Related Disorder

Interventions

DRUG: RBP-6300
DRUG: Subutex®/Suboxone®
DRUG: Placebo for RBP-6300
DRUG: Placebo for Subutex®/Suboxone®

Sponsor

Indivior Inc.